Author(s)

Shengjie Liao¹ , Xuejun Xiao² , Hao Wang¹ , Zhiwen Zhong¹ , Xiaohui Li¹ , Chengfeng Huang¹ , Xiaoshen Zhang^1*

Affiliation(s)

¹Department of Cardiovascular Surgery, the First Affiliated Hospital of Jinan University, Guangzhou, 510630, China. 

²Guangdong Cardiovascular Institute, Guangdong General Hospital, Guangzhou, 510080, China

Corresponding Author

Xiaoshen Zhang

ABSTRACT

Objectives: To discuss the near to mid-term efficacy of patients undergoing concomitant totally thoracoscopic TVP performed by the same surgeon, using retrospective analysis and follow-up.Methods: A total of 367 patients with preoperative TR undergoing concomitant totally thoracoscopic TVP performed by the same surgeon between August 2011 and December 2016 were enrolled in this study. The patients were divided into ring group and suture group based on TVP technique. The transthoracic echocardiography was performed and data were gathered before surgery, 1 week, 3 months, and 1 year after surgery.Results: No death occurred after surgery and all patients were discharged. The median follow-up time was 3.4 months. The longest follow-up time was 33 months. After the surgery, LVEF improved significantly, and the diameter of RV and the pulmonary artery pressure were significantly reduced compared with that before the surgery.Conclusions: The concomitant totally thoracoscopic TVP is reliable, effective, and safe. The results in the near to mid-term were satisfactory.

KEYWORDS

Tricuspid valve repair; Thoracoscopic; Follow-up

CITE THIS PAPER

Shengjie Liao, Xuejun Xiao, Hao Wang, Zhiwen Zhong, Xiaohui Li, Chengfeng Huang, Xiaoshen Zhang. The Near to Mid-Term Study of concomitant Totally Thoracoscopic tricuspid Valve Repair in 367 Cases. Acta Translational Medicine. 2018, 1(1): 8-12.

REFERENCES

[1] Antunes MJ, Rodriguez-Palomares J, Prendergast B, et al. Management of tricuspid valve regurgitation: Position statement of the European Society of Cardiology Working Groups of Cardiovascular Surgery and Valvular Heart Disease. Eur J Cardiothorac Surg 2017;52:1022-30.
[2] Takano H, Hiramatsu M, Kida H, et al. Severe tricuspid regurgitation after mitral valve surgery: the risk factors and results of the aggressive application of prophylactic tricuspid valve repair. Surg Today 2017;47:445-56.
[3] Pfannmueller B, Misfeld M, Haensig M, Davierwala P, Mohr FW. Tricuspid Valve Repair after Previous Mitral Valve Surgery. Thorac Cardiovasc Surg 2017;65:601-5.
[4] Rogers JH, Bolling SF. Valve repair for functional tricuspid valve regurgitation: anatomical and surgical considerations. Semin Thorac Cardiovasc Surg 2010;22:84-9.
[5] Saran N, Dearani JA. Tricuspid Valve Repair: How I Teach It. Ann Thorac Surg 2018;105:675-9.
[6] Chikwe J, Itagaki S, Anyanwu A, Adams DH. Impact of Concomitant Tricuspid Annuloplasty on Tricuspid Regurgitation, Right Ventricular Function, and Pulmonary Artery Hypertension After Repair of Mitral Valve Prolapse. J Am Coll Cardiol 2015;65:1931-8.
[7] Goldstone AB, Howard JL, Cohen JE, et al. Natural history of coexistent tricuspid regurgitation in patients with degenerative mitral valve disease: implications for future guidelines. J Thorac Cardiovasc Surg 2014;148:2802-9.
[8] Nishimura RA, Otto CM, Bonow RO, et al. 2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol 2017;70:252-89.
[9] Zhu TY, Wang JG, Meng X. Does concomitant tricuspid annuloplasty increase perioperative mortality and morbidity when correcting left-sided valve disease? Interact Cardiovasc Thorac Surg 2015;20:114-8.
[10] Badhwar V, Rankin JS, He M, et al. Performing Concomitant Tricuspid Valve Repair at the Time of Mitral Valve Operations Is Not Associated With Increased Operative Mortality. Ann Thorac Surg 2017;103:587-93.
[11] Pfannmueller B, Verevkin A, Borger MA, et al. Role of tricuspid valve repair for moderate tricuspid regurgitation during minimally invasive mitral valve surgery. Thorac Cardiovasc Surg 2013;61:386-91.
[12] Yamada T, Ochiai R, Takeda J, Shin H, Yozu R. Comparison of early postoperative quality of life in minimally invasive versus conventional valve surgery. J Anesth 2003;17:171-6.
[13] Shinn SH, Dayan V, Schaff HV, et al. Outcomes of ring versus suture annuloplasty for tricuspid valve repair in patients undergoing mitral valve surgery. J Thorac Cardiovasc Surg 2016;152:406-15 e3.
[14] Charfeddine S, Hammami R, Triki F, et al. [Plastic repair of tricuspid valve: Carpentier's ring annuloplasty versus De VEGA technique]. Pan Afr Med J 2017;27:119.
[15] Baumgartner H, Falk V, Bax JJ, et al. 2017 ESC/EACTS Guidelines for the management of valvular heart disease The Task Force for the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). European Heart Journal 2017;38:2739-+.
[16] Marsico R, Bruno VD, Chivasso P, et al. Impact of Isolated Tricuspid Valve Repair on Right Ventricular Remodelling in an Adult Congenital Heart Disease Population. Front Cardiovasc Med 2017;4:21.